Atorvastatin, commonly known as Lipitor, is a widely prescribed medication used to lower cholesterol levels and prevent cardiovascular disease. However, when it comes to safety during development, there are some crucial considerations to keep in mind.

During pregnancy, Lipitor should be used with caution due to the potential for harm to the fetus. Studies have shown that exposure to statins during pregnancy, particularly in the first trimester, may be associated with an increased risk of congenital anomalies and miscarriage [1]. The FDA has categorized atorvastatin as a pregnancy category X, indicating that its use is contraindicated in pregnant women [2].

Additionally, Lipitor can pass into breast milk and may pose a risk to a nursing infant, particularly if used in high doses or for extended periods. As a precautionary measure, the manufacturer recommends discontinuing Lipitor while breastfeeding [3].

However, for people of reproductive age who are not pregnant or breastfeeding, the safety of Lipitor can be reassuring. Research has shown that the benefits of statins, including atorvastatin, in reducing cardiovascular risk outweigh the potential risks, even in patients with high blood sugar, kidney disease, or liver dysfunction [4].

To ensure safe use, it's essential to carefully weigh the potential benefits and risks of Lipitor with your healthcare provider. They will consider your medical history, the severity of your cholesterol levels, and other factors to determine the best treatment plan for you.

Please consult the following sources for more information:

[1] Lipitor (atorvastatin calcium) - FDA prescribing information, https://www.fda.gov/drugs/atypical-antipsychotics/lipitor-atorvastatin-calcium-label

[2] Pregnancy and Statins, MedlinePlus, https://medlineplus.gov/ency/article/003069.htm

[3] Lipitor (atorvastatin calcium) - Breastfeeding, https://www.drugs.com/monograph/lipitor-atorvastatin-calcium-breasfeeding.html

[4] Use of statins in adults with type 2 diabetes, American College of Cardiology, https://www.cardiosource.org/-/media/ACCMedia/Advocacy-and-Publications/Position-Statements-and-Guidelines/Statin-therapy-in-dyabetes.ashx

Sources:
1. https://www.fda.gov/drugs/atypical-antipsychotics/lipitor-atorvastatin-calcium-label
2. https://medlineplus.gov/ency/article/003069.htm
3. https://www.drugs.com/monograph/lipitor-atorvastatin-calcium-breasfeeding.html
4. https://www.cardiosource.org/-/media/ACCMedia/Advocacy-and-Publications/Position-Statements-and-Guidelines/Statin-therapy-in-dyabetes.ashx